Skip to main content
16 January 2021
Last updated:
Saturday 16 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Regulation & Policy

EU gives conditional approval for Moderna vaccine

Wednesday 6 January 2021
Country

Netherlands

The European Commission has granted a conditional marketing authorisation for a Covid-19 vaccine developed by Moderna Inc based on clinical data showing an efficacy rate of 94.1%. The vaccine, COVID-19 Vaccine Moderna, is to be administered to people from 18 years of age. It is the second Covid-19 vaccine to be approved by the EU following a recommendation by the European Medicines Agency. The first was a vaccine developed by BioNTech SE and Pfizer Inc. Both vaccines are based on messenger RNA (mRNA) technology.

Read more

FDA cautions against altering vaccine dosing

Tuesday 5 January 2021
Country

United States

The US Food and Drug Administration has cautioned against altering the dosing regimen for Covid-19 vaccines launched on the US market, saying that any changes not supported by clinical trial data would be “concerning.” The agency specifically warned against using a single dose regimen and/or administering less than the dose studied in clinical trials.

Read more

UK approves second Covid-19 vaccine

Wednesday 30 December 2020
Country

United Kingdom

The UK has approved a second vaccine to prevent Covid-19 paving the way for a stepped up campaign to immunise the population just as hospitals across the country face a sharp rise in admissions from the pandemic. The vaccine, AZD1222, was developed by Oxford University and AstraZeneca Plc and received an emergency authorisation on 30 December – a little more than four weeks after a vaccine from Pfizer Inc and BioNTech was given clearance.

Read more

Pfizer/BioNTech vaccine clears EU

Monday 21 December 2020
Country

Belgium

The Covid-19 vaccine developed by BioNTech SE in partnership with Pfizer Inc received a conditional marketing authorisation in the EU on 21 December – only hours after having been given a positive opinion by the European Medicines Agency.

Read more

EUA for Moderna Covid-19 vaccine

Saturday 19 December 2020
Country

United States

The US Food and Drug Administration has issued an emergency use authorisation to Moderna Inc for a vaccine for Covid-19 following trial data showing it was 94.1% effective in preventing the disease. The decision comes just a week after the agency issued an emergency authorisation for a vaccine developed by BioNTech SE and its partner Pfizer Inc. Both vaccines are based on messenger RNA (mRNA), a technology never before used in a human vaccine. The two vaccines work by instructing cells in the body to make copies of the SARS-CoV-2 spike protein.

Read more

No US filing for filgotinib in RA

Wednesday 16 December 2020
Country

Belgium

Gilead Sciences Inc and Galapagos NV have dropped plans to make a new submission in the US for their small molecule drug Jyseleca (filgotinib) in rheumatoid arthritis (RA) following a meeting with the Food and Drug Administration. The parties discussed the points raised in the agency’s complete response letter in August in which it refused to approve the drug because of concerns about its benefit/risk profile at a dose of 200 mg.

Read more

FDA issues EUA for Pfizer/BioNTech vaccine

Saturday 12 December 2020
Country

United States

The US has become the second western country to give an emergency use authorisation to a Covid-19 vaccine developed by BioNTech SE in partnership with Pfizer Inc. The vaccine, BNT162b2, is based on messenger RNA (mRNA), a technology never before used in a human vaccine. It was given an emergency authorisation by the Food and Drug Administration on 11 December for individuals 16 years and over.

Read more

Post Brexit trade deal still unresolved

Saturday 5 December 2020
Country

United Kingdom

An agreement setting the terms of trade between the UK and the European Union following Brexit remains unresolved, according to the European Commission. The two sides have been negotiating for weeks to reach a trade agreement that would take effect from 1 January 2021. A telephone call on 5 December between the UK Prime Minister Boris Johnson and the European Commission President Ursula von der Leyen did not resolve differences on three issues. These issues are maintaining a level playing field for trade; fishing rights and governance.

Read more

FDA approves imaging drug for prostate cancer

Wednesday 2 December 2020
Country

United States

The first drug for imaging prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer was approved by the US Food and Drug Administration on 1 December. It is designed to be used with positron emission tomography (PET). The drug, Gallium 68 PSMA-11, is indicated for patients with suspected prostate cancer metastasis who are potentially curable by surgery or radiation therapy. It is also indicated for patients with suspected prostate cancer recurrence based on elevated prostate-specific antigen (PSA) levels.

Read more

UK waves through Pfizer-BioNTech vaccine

Wednesday 2 December 2020
Country

United Kingdom

The UK government has authorised the emergency use of a new vaccine for the prevention of Covid-19 from Pfizer Inc and BioNTech SE – the first approval of a pharmaceutical product based on messenger RNA (mRNA) technology. The decision, announced on 2 December, was based on a recommendation of the Medicines and Healthcare products Regulatory Agency (MHRA), the independent regulator. It follows the publication of Phase 3 data for the vaccine showing that it achieved an efficacy rate of 95%.

Read more

Pagination

  • Page 1
  • Next page ››
Subscribe to Regulation & Policy

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021
Sam Herbert becomes COO at Clinigen
Wednesday January 6 2021
Wolfgang Baiker becomes CEO at Adrenomed
Wednesday January 6 2021
Alligator Bioscience appoints new CMO
Tuesday December 29 2020

© 2021 Evernow Publishing Ltd. Powered by Drupal.